Acumen Pharmaceuticals, Inc.

Basic Information

Acumen Pharmaceuticals, Inc.
385 Oyster Point Blvd.
South San Francisco, CA, 94080

Company Profile

n/a

Additional Details

Field Value
DUNS: n/a
Hubzone Owned: N
Socially and Economically Disadvantaged: N
Woman Owned: N
Number of Employees: n/a


  1. Drug discovery of anti-ADDL therapeutics for Alzheimer's

    Amount: $183,750.00

    DESCRIPTION (provided by applicant): Recent evidence suggests that the primary cause of Alzheimer's disease is the progressive accumulation of neurotpxic oligomeric assemblies of the Abeta 1-42 prote ...

    SBIR Phase I 2005 Department of Health and Human Services
  2. Biomarker for Alzheimer's Related Cognitive Deficits

    Amount: $145,774.00

    DESCRIPTION (provided by applicant): The molecular and cellular details underlying Alzheimer's disease (AD) are being defined at an accelerating pace, leading to new therapeutic discovery efforts tha ...

    SBIR Phase I 2005 Department of Health and Human Services

Agency Micro-sites

US Flag An Official Website of the United States Government